GILDGilead Sciences Inc

CSNasdaq (XNAS)·USD

Identity

Security key: 16001
Ticker: GILD
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 1992-01-22
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: GILD

Detail

Enriched 2026-08-14 20:47

Market cap: $168,472,706,909.85
Shares outstanding (class): 1,239,955,155
Shares outstanding (weighted): 1,239,955,155
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 17,000
Location: FOSTER CITY, CA
Homepage: https://www.gilead.com
Description: Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

Market cap and share counts drift.

Funds holding this security

671 funds · 702 positions · $43.51B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$5.50B	0.28%	39,428,113 NS	FIGI
VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS	VOO	$4.39B	0.31%	31,528,197 NS	FIGI
Invesco QQQ Trust, Series 1 Invesco QQQ Trust, Series 1	QQQ	$3.64B	0.98%	26,151,783 NS	FIGI
Dodge & Cox Stock Fund Dodge & Cox Funds	—	$2.52B	2.20%	18,093,312 NS	FIGI
iShares Core S&P 500 ETF iShares Trust	IVV	$2.22B	0.31%	15,956,074 NS	FIGI
N/A —	—	$2.01B	0.31%	14,446,028 NS	FIGI
JPMorgan Large Cap Growth Fund JPMorgan Trust II	—	$1.72B	1.60%	12,360,249 NS	FIGI
VANGUARD VALUE INDEX FUND VANGUARD INDEX FUNDS	VTV	$1.60B	0.71%	11,482,635 NS	FIGI
Fidelity Contrafund Fidelity Contrafund	—	$1.44B	0.91%	10,331,523 NS	FIGI
American Balanced Fund American Balanced Fund	—	$1.37B	0.52%	9,837,660 NS	FIGI
State Street(R) Health Care Select Sector SPDR(… SELECT SECTOR SPDR TRUST	XLV	$1.26B	3.26%	9,028,573 NS	FIGI
VANGUARD INSTITUTIONAL INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS	—	$974.97M	0.31%	6,995,572 NS	FIGI
VANGUARD EQUITY INCOME FUND VANGUARD FENWAY FUNDS	—	$849.68M	1.36%	6,096,560 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$629.35M	7.75%	4,515,707 NS	FIGI
T. Rowe Price Value Fund, Inc. T. ROWE PRICE VALUE FUND, INC.	—	$575.19M	1.80%	4,127,097 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERGILD
FIGI_COMPOSITEBBG000CKGBP2
FIGI_SHARE_CLASSBBG001S6Y1X7
CIK0000882095
ISINUS3755581036
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Gilead Sciences is a biopharmaceutical company focused on antiviral and oncology drugs, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.